Global Specialty Pharmaceutical Market Insights, Forecast to 2025
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Specialty Pharmaceutical Quarterly Market Size Analysis
- 2.1 Specialty Pharmaceutical Business Impact Assessment - COVID-19
- 2.1.1 Global Specialty Pharmaceutical Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.1.2 Global Specialty Pharmaceutical Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Specialty Pharmaceutical Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 Global Specialty Pharmaceutical Quarterly Market Size by Manufacturers, 2019 VS 2020
- 3.2 Global Specialty Pharmaceutical Factory Price by Manufacturers
- 3.3 Location of Key Manufacturers Specialty Pharmaceutical Manufacturing Factories and Area Served
- 3.4 Date of Key Manufacturers Enter into Specialty Pharmaceutical Market
- 3.5 Key Manufacturers Specialty Pharmaceutical Product Offered
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Specialty Pharmaceutical Segments, By Type
- 4.1 Introduction
- 1.4.1 Antibody
- 1.4.2 Hormone
- 1.4.3 Growth Factors
- 1.4.4 Other
- 4.2 By Type, Global Specialty Pharmaceutical Market Size, 2019-2021
- 4.2.1 By Type, Global Specialty Pharmaceutical Market Size by Type, 2020-2021
- 4.2.2 By Type, Global Specialty Pharmaceutical Price, 2020-2021
5 Impact of Covid-19 on Specialty Pharmaceutical Segments, By Application
- 5.1 Overview
- 5.5.1 Tumor
- 5.5.2 Diabetes
- 5.5.3 Cardiovascular
- 5.5.4 Hemophilia
- 5.5.5 Other
- 5.2 By Application, Global Specialty Pharmaceutical Market Size, 2019-2021
- 5.2.1 By Application, Global Specialty Pharmaceutical Market Size by Application, 2019-2021
- 5.2.2 By Application, Global Specialty Pharmaceutical Price, 2020-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Pfizer
- 7.1.1 Pfizer Business Overview
- 7.1.2 Pfizer Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.1.3 Pfizer Specialty Pharmaceutical Product Introduction
- 7.1.4 Pfizer Response to COVID-19 and Related Developments
- 7.2 Roche
- 7.2.1 Roche Business Overview
- 7.2.2 Roche Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.2.3 Roche Specialty Pharmaceutical Product Introduction
- 7.2.4 Roche Response to COVID-19 and Related Developments
- 7.3 Amgen
- 7.3.1 Amgen Business Overview
- 7.3.2 Amgen Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.3.3 Amgen Specialty Pharmaceutical Product Introduction
- 7.3.4 Amgen Response to COVID-19 and Related Developments
- 7.4 AbbVie
- 7.4.1 AbbVie Business Overview
- 7.4.2 AbbVie Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.4.3 AbbVie Specialty Pharmaceutical Product Introduction
- 7.4.4 AbbVie Response to COVID-19 and Related Developments
- 7.5 Novo Nordisk
- 7.5.1 Novo Nordisk Business Overview
- 7.5.2 Novo Nordisk Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.5.3 Novo Nordisk Specialty Pharmaceutical Product Introduction
- 7.5.4 Novo Nordisk Response to COVID-19 and Related Developments
- 7.6 Johnson & Johnson
- 7.6.1 Johnson & Johnson Business Overview
- 7.6.2 Johnson & Johnson Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.6.3 Johnson & Johnson Specialty Pharmaceutical Product Introduction
- 7.6.4 Johnson & Johnson Response to COVID-19 and Related Developments
- 7.7 Sanofi-Aventis
- 7.7.1 Sanofi-Aventis Business Overview
- 7.7.2 Sanofi-Aventis Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.7.3 Sanofi-Aventis Specialty Pharmaceutical Product Introduction
- 7.7.4 Sanofi-Aventis Response to COVID-19 and Related Developments
- 7.8 Merck
- 7.8.1 Merck Business Overview
- 7.8.2 Merck Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.8.3 Merck Specialty Pharmaceutical Product Introduction
- 7.8.4 Merck Response to COVID-19 and Related Developments
- 7.9 Eli Lilly
- 7.9.1 Eli Lilly Business Overview
- 7.9.2 Eli Lilly Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.9.3 Eli Lilly Specialty Pharmaceutical Product Introduction
- 7.9.4 Eli Lilly Response to COVID-19 and Related Developments
- 7.10 Novartis
- 7.10.1 Novartis Business Overview
- 7.10.2 Novartis Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.10.3 Novartis Specialty Pharmaceutical Product Introduction
- 7.10.4 Novartis Response to COVID-19 and Related Developments
- 7.11 3sbio
- 7.11.1 3sbio Business Overview
- 7.11.2 3sbio Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.11.3 3sbio Specialty Pharmaceutical Product Introduction
- 7.11.4 3sbio Response to COVID-19 and Related Developments
- 7.12 Changchun High Tech
- 7.12.1 Changchun High Tech Business Overview
- 7.12.2 Changchun High Tech Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.12.3 Changchun High Tech Specialty Pharmaceutical Product Introduction
- 7.12.4 Changchun High Tech Response to COVID-19 and Related Developments
- 7.13 CP Guojian Pharmacy
- 7.13.1 CP Guojian Pharmacy Business Overview
- 7.13.2 CP Guojian Pharmacy Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Product Introduction
- 7.13.4 CP Guojian Pharmacy Response to COVID-19 and Related Developments
- 7.14 Biotech Pharma
- 7.14.1 Biotech Pharma Business Overview
- 7.14.2 Biotech Pharma Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.14.3 Biotech Pharma Specialty Pharmaceutical Product Introduction
- 7.14.4 Biotech Pharma Response to COVID-19 and Related Developments
- 7.15 Gelgen Biopharma
- 7.15.1 Gelgen Biopharma Business Overview
- 7.15.2 Gelgen Biopharma Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.15.3 Gelgen Biopharma Specialty Pharmaceutical Product Introduction
- 7.15.4 Gelgen Biopharma Response to COVID-19 and Related Developments
- 7.16 Innovent
- 7.16.1 Innovent Business Overview
- 7.16.2 Innovent Specialty Pharmaceutical Quarterly Production and Revenue, 2020
- 7.16.3 Innovent Specialty Pharmaceutical Product Introduction
- 7.16.4 Innovent Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
- 8.1 Specialty Pharmaceutical Supply Chain Analysis
- 8.1.1 Specialty Pharmaceutical Supply Chain Analysis
- 8.1.2 Covid-19 Impact on Specialty Pharmaceutical Supply Chain
- 8.2 Distribution Channels Analysis
- 8.2.1 Specialty Pharmaceutical Distribution Channels
- 8.2.2 Covid-19 Impact on Specialty Pharmaceutical Distribution Channels
- 8.2.3 Specialty Pharmaceutical Distributors
- 8.3 Specialty Pharmaceutical Customers
9 Key Findings
10 Appendix
- 10.1 About Us
This report covers market size and forecasts of Specialty Pharmaceutical, including the following market information:
Global Specialty Pharmaceutical Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Specialty Pharmaceutical Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Specialty Pharmaceutical Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Specialty Pharmaceutical Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)
Key market players
Major competitors identified in this market include Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson, Sanofi-Aventis, Merck, Eli Lilly, Novartis, 3sbio, Changchun High Tech, CP Guojian Pharmacy, Biotech Pharma, Gelgen Biopharma, Innovent, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Antibody
Hormone
Growth Factors
Other
Based on the Application:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other